Syntr Health Technologies, Inc.
This is an multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in Orthopedic Surgery, specifically Knee Osteoarthritis. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites or Standard of Care.
Knee Osteoarthritis
SyntrFuge System
Triamcinolone Injection
NA
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 176 participants |
Masking : | SINGLE |
Primary Purpose : | TREATMENT |
Official Title : | Multi-Center, Randomized Controlled Trial Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis |
Actual Study Start Date : | 2024-10-01 |
Estimated Primary Completion Date : | 2025-12 |
Estimated Study Completion Date : | 2025-12 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 70 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Irvine Site 1
Irvine, California, United States, 92618
RECRUITING
Irvine Site 2
Irvine, California, United States, 92618